A Brief Review of the Estimated Economic Burden of Sexually Transmitted Diseases in the United States: Inflation-Adjusted Updates of Previously Published Cost Studies

In Brief We conducted a literature review of studies of the economic burden of sexually transmitted diseases in the United States. The annual direct medical cost of sexually transmitted diseases (including human immunodeficiency virus) has been estimated to be $16.9 billion (range: $13.9–$23.0 billion) in 2010 US dollars. Based on a literature review, the annual direct medical cost of sexually transmitted diseased (including human immunodeficiency virus) has been estimated to be 16.9 billion (range: $13.9–23.0 billion) in the 2010 US dollars.